Intracranial hypertension and papilledema associated with nalidixic acid therapy.
D002648:Child; D004172:Diplopia / Q000139:chemically induced; D005260:Female; D006801:Humans; D009268:Nalidixic Acid / Q000009:adverse effects* / Q000627:therapeutic use; D009900:Optic Nerve / Q000187:drug effects; D010211:Papilledema / Q000139:chemically induced*; D011512:Proteus Infections / Q000188:drug therapy; D011513:Proteus mirabilis; D011559:Pseudotumor Cerebri / Q000139:chemically induced*; D013285:Strabismus / Q000139:chemically induced
D009268:Nalidixic Acid